Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2015-09-29 Legal Proceedings Report
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose: Bundesgerichtsurteil: Versand von rezeptfreien Arzneimitteln wird faktisch verunmoglicht
Legal Proceedings Report Classification · 99% confidence The document is a news release dated September 29, 2015, from Zur Rose Group AG, announcing a Federal Court ruling that effectively prevents the shipment of non-prescription medicines. It discusses the legal implications, quotes the CEO, and provides company background. This type of announcement, detailing a significant legal event or regulatory decision impacting the business, fits best under the category of Legal Proceedings Report (LTR) or potentially a general Regulatory Filing (RNS) if LTR was not available. Since the core subject is a court ruling ('Bundesgerichtsurteil') and its consequences, LTR is the most specific fit. It is not an earnings release (ER), annual report (10-K), or a proxy statement (DEF 14A/PSI). Given the content focuses entirely on a legal matter, LTR is selected.
2015-09-29 German
Zur Rose Group: Anspruchsvolles erstes Halbjahr 2015
Earnings Release Classification · 100% confidence The document is titled 'Zur Rose Group: Anspruchsvolles erstes Halbjahr 2015' (Challenging first half-year 2015) and contains detailed consolidated financial statements (Erfolgsrechnung and Bilanz) for the period January to June 2015, comparing them to the prior year. The text explicitly discusses revenue, EBITDA, net income, and provides an outlook for the full year. This content structure, focusing on comprehensive financial results for a period shorter than a full year (six months), clearly identifies it as an Interim/Quarterly Report. The presence of financial tables and detailed operational commentary aligns perfectly with the definition of an Interim Report (IR). It is not a brief announcement (RPA) as it contains the full results and tables, nor is it the Annual Report (10-K). H1 2015
2015-08-24 German
Zur Rose Group: un premier semestre 2015 difficile
Earnings Release Classification · 100% confidence The document is titled "Communiqué de presse" (Press Release) and details the financial performance for the "premier semestre 2015" (first half of 2015), including key figures like revenue, EBITDA, and net result, along with management commentary and outlook. This structure—a formal announcement of period results, often released before or instead of the full, detailed report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or a comprehensive Interim Report (IR) which usually contains more extensive notes and disclosures, but rather the initial summary announcement. The presence of a detailed consolidated income statement and balance sheet supports the classification as a results announcement, fitting the 'ER' definition best, as it is the initial announcement of periodical financial results. H1 2015
2015-08-24 French
Annual Report 2014
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2014' (Annual Report 2014) for the Zur Rose-Gruppe. It contains a comprehensive overview of the company, including financial statements, key performance indicators (Kennzahlen), a letter to shareholders (Aktionärsbrief), management discussion and analysis, corporate governance details, and an outlook for the future. As it is a full annual report containing substantive financial data and analysis, it is classified as a 10-K (Annual Report). FY 2014
2015-04-11 English
Geschäftsbericht 2014
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2014' (Annual Report 2014) for the Zur Rose-Gruppe. It contains a comprehensive overview of the company, including financial statements, key performance indicators (Kennzahlen), a letter to shareholders (Aktionärsbrief), management discussion and analysis, corporate governance details, and an outlook for the future. As it is a full annual report containing substantive financial data and analysis, it is classified as a 10-K (Annual Report). FY 2014
2015-04-11 German
Zur Rose mit Ergebnissprung im Geschaftsjahr 2014
Earnings Release Classification · 100% confidence The document is a detailed press release dated April 9, 2015, titled "Zur Rose mit Ergebnissprung im Geschäftsjahr 2014" (Zur Rose with earnings jump in fiscal year 2014). It contains key financial highlights for the full year 2014, including revenue (915.6 million CHF), EBITDA (17.3 million CHF), and net income (7.2 million CHF), presented in a table format. It also includes management commentary on business segments (DocMorris, Zur Rose Pharma) and an outlook for 2015. This structure—a comprehensive summary of annual financial performance and operational review—is characteristic of an Earnings Release (ER) or, given the depth and inclusion of full-year audited-like figures, it strongly resembles the content typically found in an Annual Report (10-K) or a detailed Interim/Quarterly Report (IR). However, since it explicitly covers the *full fiscal year* and provides a detailed breakdown of results, it is most accurately classified as a comprehensive annual financial disclosure. Since the document is a press release announcing the results and not the formal 10-K filing itself, and it covers the full year, it is best classified as an Earnings Release (ER) which summarizes the annual performance, or potentially an Interim Report (IR) if the company uses this format for its annual summary, but ER is more common for initial public announcements of yearly results. Given the comprehensive nature covering the entire year and the explicit mention of the 'Jahresergebnis' (Annual Result), it functions as the primary announcement of the annual results, fitting the 'ER' definition best, although it is more detailed than a typical quarterly ER. If it were the full statutory filing, it would be 10-K. Since it is a news release detailing the full year's performance, ER is the most appropriate fit among the options for a results announcement. FY 2014
2015-04-09 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.